We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$319M
AUM Growth
+$18.9M
Cap. Flow
+$6.94M
Cap. Flow %
2.17%
Top 10 Hldgs %
37.77%
Holding
106
New
6
Increased
17
Reduced
26
Closed
10

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$6.87M
2
IBM icon
IBM
IBM
+$6.33M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.96M
4
SYK icon
Stryker
SYK
+$2.76M
5
CI icon
Cigna
CI
+$2.33M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$3.67M
2
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
+$1.74M
3
IBB icon
iShares Biotechnology ETF
IBB
+$1.38M
4
KKR icon
KKR & Co
KKR
+$1.27M
5
TRGP icon
Targa Resources
TRGP
+$841K

Sector Composition

Rank Sector Weight
1 Healthcare 31.66%
2 Technology 16.82%
3 Communication Services 16.5%
4 Industrials 8.67%
5 Miscellaneous 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LADR
76
Ladder Capital
LADR
$1.25B
$273K 0.09%
+17,500
New +$263K
SPY icon
77
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$264K 0.08%
973
– –
RCM
78
DELISTED
R1 RCM Inc. Common Stock
RCM
$260K 0.08%
30,000
– –
XLK icon
79
State Street Technology Select Sector SPDR ETF
XLK
$121B
$252K 0.08%
7,242
– –
BRK.B icon
80
Berkshire Hathaway Class B
BRK.B
$1.08T
$243K 0.08%
1,300
– –
LSXMA
81
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$241K 0.08%
7,405
– –
DD icon
82
DuPont de Nemours
DD
$18.5B
$228K 0.07%
1,366
– –
TJX icon
83
TJX Companies
TJX
$149B
$228K 0.07%
+4,800
New +$211K
BABA icon
84
Alibaba
BABA
$296B
$218K 0.07%
1,175
-235
-17% -$44.8K
SIRI icon
85
SiriusXM
SIRI
$9.62B
$116K 0.04%
1,721
+449
+35% +$30.3K
BIB icon
86
ProShares Ultra NASDAQ Biotechnology
BIB
$98.9M
– –
-10,000
Closed -$551K
BMRN icon
87
BioMarin Pharmaceuticals
BMRN
$12.5B
– –
-10,000
Closed -$811K
NXH
88
Neighborhood Intelligence Inc
NXH
$375M
– –
-14,356
Closed -$391K
KKR icon
89
KKR & Co
KKR
$97.6B
– –
-62,479
Closed -$1.27M
LRCX icon
90
Lam Research
LRCX
$378B
– –
-20,750
Closed -$422K
TRGP icon
91
Targa Resources
TRGP
$61.7B
– –
-19,122
Closed -$841K
VSTM icon
92
Verastem
VSTM
$654M
– –
-15,704
Closed -$562K
JOYY
93
JOYY Inc
JOYY
$3.65B
– –
-3,000
Closed -$316K
ARMO
94
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
– –
-46,574
Closed -$1.74M
1 2 3
4

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Private Capital Advisors held 106 positions worth $319M, up 6.3% from $300M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Private Capital Advisors's Q2 2018 filing shows 6 new, 17 increased, 26 reduced and 10 closed positions. Its largest new stake was Karyopharm Therapeutics: 27,793 shares worth $7.08M. The largest sale was Meta Platforms (Facebook), an estimated $3.67M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.

  • Private Capital Advisors's largest Q2 2018 buy was Karyopharm Therapeutics: 27,793 shares worth $7.08M.
  • Private Capital Advisors added most to IBM in Q2 2018, an estimated $6.33M increase.
  • Private Capital Advisors's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $3.67M.
  • Private Capital Advisors fully exited ARMO BioSciences, Inc. Common Stock in Q2 2018, selling an estimated $1.74M.
  • Private Capital Advisors's ten largest holdings make up 38% of its $319M portfolio in Q2 2018.
  • Private Capital Advisors opened 6 new positions and closed 10 in Q2 2018.
  • Private Capital Advisors's portfolio value rose 6.3% quarter-over-quarter to $319M.

Based on Private Capital Advisors's 13F filing for Q2 2018, filed 10 Jul 2018.